kevin kalinsky, md, offers considerations when treating patients with hr , her2- breast cancer
Published 3 years ago • 51 plays • Length 1:20
Download video MP4
Download video MP3
Similar videos
-
1:57
kevin kalinsky, md, regarding ctcs as a predictor of overall survival in metastatic breast cancer
-
39:22
optimizing therapy in her2 disease with dr. kevin kalinsky
-
5:14
adjuvant chemo omission feasible for certain postmenopausal breast cancer patients | kevin kalinsky
-
41:49
winship grand rounds: april 13, 2022 - kevin kalinsky, md, ms
-
0:53
dr. kalinsky on cns involvement in her2 breast cancer
-
7:20
5. hallmarks of cancer (part 2)
-
2:29
balding linked to skin cancer, research confirms
-
10:32
cancer and aging
-
0:47
kevin kalinsky, md | advances in breast cancers at 2019 asco direct highlights philadelphia
-
1:49
kalinsky discusses results from rxponder breast cancer clinical trial
-
0:28
kevin kalinsky, md | key takeaways on breast cancers at 2019 asco direct highlights philadelphia
-
1:35
dr. kalinsky on ruxolitinib plus trastuzumab in her2-positive breast cancer
-
2:48
kevin kalinsky, md, summarizes recent clinical data regarding the role of cdk 4/6 inhibitors
-
2:22
kevin kalinsky, md, shares impressions of the rxponder clinical trial presented at sabcs 2020
-
1:10
dr. kalinsky discusses the evolution of her2 breast cancer
-
47:36
friends of winship learn and live - breast cancer update
-
1:50
dr lynce on ongoing trials evaluating novel combinations in inflammatory breast cancer
-
0:43
dr. kalinsky discusses biosimilars in breast cancer
-
1:45
dr. kalinsky on neratinib and tucatinib in her2 metastatic breast cancer
-
3:52
case study: her2-positive oligometastatic breast cancer
-
3:08
case 2: er breast cancer
-
0:41
priya rastogi, md, elaborates on the role of abemaciclib in hr , her2- node positive breast cancer
Clip.africa.com - Privacy-policy